MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03676cam a22002774a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20231011163658.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
070116s2007 moua b 001 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780323044868 (pbk. : alk. paper) |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
BUL |
| Transcribing agency |
BUL |
| Modifying agency |
BUL |
| Language of cataloging |
eng |
| Description conventions |
rda |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
QV 4 L729p 2007 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Lilley, Linda Lane. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Pharmacology and the nursing process / |
| Statement of responsibility, etc. |
Linda Lane Lilley, Scott Harrington, Julie S. Snyder ; with study skills content by Diana Savoca. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
5th edition |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
St. Louis, MO : |
| Name of publisher, distributor, etc. |
Mosby/Elsevier, |
| Date of publication, distribution, etc. |
c2007. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xxii, 969 p. : |
| Other physical details |
col. ill. ; |
| Dimensions |
28 cm. + |
| Accompanying material |
1CD-ROM |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references (p. 909-920) and index. |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Contents<br/><br/>Part 1: Pharmacology Basics<br/>1. The nursing process and drug therapy<br/>2. Pharmacologic principles <br/>3. Life span considerations <br/>4. Cultural, legal, and ethical considerations<br/>5. Medication errors : preventing and responding <br/>6. Patient education and drug therapy <br/>7. Over-the-counter drugs and herbal and dietary supplements<br/>8. Substance abuse <br/>9. Photo atlas of drug administration <br/><br/>Part 2: Drugs affecting the central nervous system<br/>10. Analgesic drugs <br/>11. General and local anesthetics <br/>12. Central nervous system depressants and muscle relaxants <br/>13. Antiepileptic drugs <br/>14. Antiparkinsonian drugs <br/>15. Psychotherapeutic drugs<br/>16. Central nervous system stimulants and related drugs <br/><br/>Part 3: Drugs affecting the autonomic nervous system<br/>17. Adrenergic drugs <br/>18. Adrenergic-blocking drugs<br/>19. Cholinergic drugs <br/>20. Cholinergic-blocking drugs<br/><br/>Part 4: Drugs affecting the cardiovascular and renal systems<br/>21. Positive inotropic drugs <br/>22. Antidysrhythmic drugs<br/>23. Antianginal drugs <br/>24. Antihypertensive drugs <br/>25. Diuretic drugs <br/>26. Fluids and electrolytes <br/>27. Coagulation modifier drugs<br/><br/>Part 5: Drugs affecting the endocrine system<br/>28. Antilipemic drugs<br/>29. Pituitary drugs <br/>30. Thyroid and antithyroid drugs<br/>31. Antidiabetic drugs<br/>32. Adrenal drugs <br/>33. Women's health drugs <br/>34. Men's health drugs <br/><br/>Part 6: Drugs affecting the respiratory system<br/>35. Antihistamines, decongestants, antitussives, and expectorants <br/>36. Bronchodilators and other respiratory drugs <br/><br/>Part 7: Antiinfective and antiinflammatory drugs<br/>37. Antibiotics part 1<br/>38. Antibiotics part 2<br/>39. Antiviral drugs <br/>40. Antitubercular drugs <br/>41. Antifungal drugs <br/>42. Antimalarial, antiprotozoal, and anthelmintic drugs <br/>43. Antiseptic and disinfectant agents<br/>44. Antiinflammatory, antirheumatic, and related drugs<br/><br/>Part 8: Immune and biologic modifiers and chemotherapeutic drugs<br/>45. Immunosuppressant drugs <br/>46. Immunizing drugs and biochemical terrorism <br/>47. Antineoplastic drugs part 1 : cancer overview and cell cycle-specific drugs <br/>48. Antineoplastic drugs part 2 : cell cycle-nonspecific and miscellaneous drugs <br/>49. Biologic response-modifying drugs <br/>50. Gene therapy and pharmacogenomics <br/><br/>Part 9: Drugs affecting the gastrointestinal system and nutrition<br/>51. Acid-controlling drugs <br/>52. Antidiarrheals and laxatives<br/>53. Antiemetic and antinausea drugs<br/>54. Vitamins and minerals <br/>55. Nutrition supplements<br/><br/>Part 10: Miscellaneous therapeutics: Hematologic, dermatologic, ophthalmic, and Otic drugs<br/>56. Blood-forming drugs <br/>57. Dermatologic drugs <br/>58. Ophthalmic drugs <br/>59. Otic drugs.<br/> |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmacology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Nursing. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Harrington, Scott, |
| Titles and other words associated with a name |
PharmD. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Snyder, Julie S. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Savoca, Diane. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Book Open Access |
| Edition |
5th edition |
| Classification part |
QV 4 L729p 2007 |
| Item part |
1 |
| Call number prefix |
QV 4 |
| Call number suffix |
L729p 2007 |
